What are the indications for performing a tracheostomy in intubated ICU patients?

Indications for Tracheostomy in Intubated ICU Patients

Tracheostomy should be proposed when weaning from mechanical ventilation is prolonged (>7 days after the first spontaneous breathing trial) or in patients with acquired and potentially reversible neuromuscular disorders who fail to wean after appropriate treatment. 1

Primary Indications

Prolonged Weaning from Mechanical Ventilation

• The most common indication is prolonged mechanical ventilation, typically considered after approximately 20 days of intubation 2
• However, weaning lasting more than 7 days after the first spontaneous breathing trial is the specific threshold recommended by French expert consensus 1
• Early tracheostomy (before 3 weeks) is considered in 68% of ICUs, with a median timing of 7 days when indicated 2
• The average time from intubation to tracheostomy in practice is approximately 14-20 days 3, 2, 4

Acquired and Potentially Reversible Neuromuscular Disorders

• Tracheostomy is indicated for conditions such as Guillain-Barré syndrome, ICU-acquired weakness, myasthenia, and lupus myelitis 1
• For Guillain-Barré syndrome specifically, tracheostomy should only be considered if weaning from invasive mechanical ventilation is not achieved after completion of immunotherapy (intravenous immunoglobulins or plasma exchange) 1
• Deficit in plantar flexion at the end of immunotherapy has 82% positive predictive value for prolonged (>15 days) mechanical ventilation 1

Failure to Wean from Ventilation

• Failure of extubation is reported as an indication in 48% of ICUs 2
• This represents patients who have attempted liberation from mechanical ventilation but cannot maintain adequate respiratory function 2

Airway Protection

• Loss of airway-protecting mechanisms is a recognized indication 5
• Airway protection was the indication in 37% of tracheostomies in one series 4

Acute Respiratory Distress Syndrome (ARDS)

• ARDS requiring prolonged ventilation, including COVID-19 related ARDS, is a common indication 3
• In COVID-19 patients, the average time from intubation to tracheostomy was 19.7 days 3

Special Considerations

Chronic Respiratory Failure

• The indication for tracheostomy in patients with chronic respiratory failure should be the subject of multidisciplinary discussion 1
• Noninvasive ventilation should be considered first-line rather than tracheostomy 1
• Certain neurological disorders causing chronic respiratory failure may benefit from tracheostomy to enable mechanical ventilation and simplify airway management 1

Maxillofacial Trauma

• Maxillofacial trauma requiring prolonged airway management represents a small proportion of indications (approximately 6% of cases) 4

Clinical Benefits Supporting These Indications

Physicians perform tracheostomy because it facilitates weaning from mechanical ventilation, reduces work of breathing, increases patient comfort, allows reduction in sedation levels, helps with secretion clearance, facilitates ventilator disconnection, and enables earlier phonation, oral intake, and mobilization 5, 2

Important Caveats

• No study has provided formal evidence that tracheotomy improves survival in patients with neuromuscular disorders 1
• Tracheostomy does not reduce mortality despite its other advantages 5
• Late tracheotomy may increase the risk of ventilator-associated pneumonia 1
• The procedure is associated with both early and late complications, particularly tracheal stenosis 5

Contraindications to Consider

Before proceeding, ensure the patient does not have:

• Positive end-expiratory pressure >10 cm H₂O 4
• Previous tracheostomy 4
• Anatomic distortion of the tracheal region 4
• Coagulopathy or other bleeding disorders that cannot be corrected